Literature DB >> 14743654

Pediatric hydrocephalus: current management.

John R Kestle1.   

Abstract

Hydrocephalus is a common problem in pediatric neurology and neurosurgery. The key to the diagnosis of hydrocephalus is the clinical or radiographic progression over time. Most children who have hydrocephalus require ventriculoperitoneal shunts, but the complications of shunting remain distressingly common. Using current endoscopic techniques, a small proportion of patients can be treated without ventriculoperitoneal shunts. The population of pediatric patients who have had hydrocephalic shunts is maturing; these young adults now face issues related to independent living, pregnancy, and long-term care of their hydrocephalus.

Entities:  

Mesh:

Year:  2003        PMID: 14743654     DOI: 10.1016/s0733-8619(03)00016-1

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  17 in total

1.  Exit ventriculoperitoneal shunt; enter endoscopic third ventriculostomy (ETV): contemporary views on hydrocephalus and their implications on management.

Authors:  P Kamalo
Journal:  Malawi Med J       Date:  2013-09       Impact factor: 0.875

2.  Use of quantitative 16S rRNA PCR to determine bacterial load does not augment conventional cerebrospinal fluid (CSF) cultures among children undergoing treatment for CSF shunt infection.

Authors:  Tamara D Simon; Brian Van Yserloo; Kevin Nelson; David Gillespie; Randy Jensen; James P McAllister; Jay Riva-Cambrin; Chris Stockmann; Judy A Daly; Anne J Blaschke
Journal:  Diagn Microbiol Infect Dis       Date:  2013-08-13       Impact factor: 2.803

3.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

4.  Reactive astrocytosis in feline neonatal hydrocephalus: acute, chronic, and shunt-induced changes.

Authors:  Ramin Eskandari; Carolyn A Harris; James P McAllister
Journal:  Childs Nerv Syst       Date:  2011-08-17       Impact factor: 1.475

5.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

6.  Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.

Authors:  Matthew R Test; Kathryn B Whitlock; Marcie Langley; Jay Riva-Cambrin; John R W Kestle; Tamara D Simon
Journal:  J Neurosurg Pediatr       Date:  2019-05-03       Impact factor: 2.375

7.  Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatr       Date:  2016-09-28       Impact factor: 4.406

8.  Changes in third ventricular size in pediatric patients undergoing endoscopic third ventriculostomy.

Authors:  Jonathan Pindrik; George I Jallo; Edward S Ahn
Journal:  Childs Nerv Syst       Date:  2013-05-16       Impact factor: 1.475

9.  Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.

Authors:  Tamara D Simon; Matthew Hall; Jay Riva-Cambrin; J Elaine Albert; Howard E Jeffries; Bonnie Lafleur; J Michael Dean; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-08       Impact factor: 2.375

10.  Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis N Shannon; Mandeep Tamber; John C Wellons Iii; William E Whitehead; Nicole Mayer-Hamblett
Journal:  J Pediatric Infect Dis Soc       Date:  2019-07-01       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.